Citations 0
Editor's Correspondence
September 10, 2001

Interaction Between Angiotensin-Converting Enzyme Inhibitors and Aspirin

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Intern Med. 2001;161(16):2048. doi:

In the article by Krumholz et al1 on the interaction of aspirin and angiotensin-converting enzyme (ACE) inhibitors, the authors concluded that when prescribed together, the mortality rate after a myocardial infarction is slightly lower than it is when either drug is prescribed alone, although the added benefit is not statistically significant. They based their conclusion on the P value of a product term between both drugs entered in a Cox regression model. Hence, they use a purely statistical definition of interaction rather than a biological approach. Conclusions based on this approach of interaction are often misleading, if not incorrect, because the magnitude or statistical nonsignificance of a product term is by no means a proof of the absence of interaction.2 We believe that this interaction should be understood as the joint effect of 2 drugs in the same causal (or preventive) mechanism of a disease.3

First Page Preview View Large
First page PDF preview
First page PDF preview